Center Laboratories, Inc. (TPEX:4123)
37.05
-0.60 (-1.59%)
Dec 23, 2025, 1:30 PM CST
Center Laboratories Market Cap
Center Laboratories has a market cap or net worth of 28.11 billion as of December 23, 2025. Its market cap has decreased by -23.05% in one year.
Market Cap
28.11B
Enterprise Value
31.48B
Revenue
1.57B
Ranking
n/a
PE Ratio
16.54
Stock Price
37.05
Market Cap Chart
Since November 3, 2004, Center Laboratories's market cap has increased from 358.01M to 28.11B, an increase of 7,750.79%. That is a compound annual growth rate of 22.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 28.11B | -11.03% |
| Dec 31, 2024 | 31.59B | 3.14% |
| Dec 29, 2023 | 30.63B | 8.88% |
| Dec 30, 2022 | 28.13B | -7.93% |
| Dec 30, 2021 | 30.56B | -3.72% |
| Dec 31, 2020 | 31.74B | 30.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 252.02B |
| PharmaEssentia | 183.81B |
| Heron Neutron Medical | 82.63B |
| Lotus Pharmaceutical | 75.08B |
| Bora Pharmaceuticals Co., LTD. | 61.84B |
| Lin BioScience | 33.05B |
| Lumosa Therapeutics | 32.01B |
| Oneness Biotech | 28.18B |